In the second part of our study, we evidenced that inhibition of GLUT5 by MSNBA efficiently decreased the viability of colon cancer cells, which may be used to design an experimental treatment of CRC as well as to prevent CRC growth. Here, SLC2A5 is linked to colonic neoplasm.